France· FR:60482665
IPRATROPIUM ARROW 0,25 mg/mL ENFANTS, solution pour inhalation par nébuliseur en récipient unidose
A medicinal product containing bromure d'ipratropium monohydraté, registered in France by ARROW GENERIQUES, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BROMURE D'IPRATROPIUM MONOHYDRATÉ
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093671539430 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 1 mlEUR 8.01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bromure d'ipratropium monohydraté in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAtrovent 0,25 mg/ml Lösning för nebulisatorBoehringer Ingelheim International GmbH
- BelgiumAtrovent 0.5 mg/2 mlBoehringer Ingelheim
- NetherlandsAtrovent Unit Dose 500 microgram/2 ml, verneveloplossingBoehringer Ingelheim B.V.
- IrelandAtrovent 250 UDVs 250 micrograms/ 1ml Nebuliser SolutionBoehringer Ingelheim International GmbH
- SpainATROVENT MONODOSIS 500 mcg/ 2ml SOLUCION PARA INHALACION POR NEBULIZADORBoehringer Ingelheim Espana S.A.
- NorwayAtroventBoehringer Ingelheim International GmbH
- FinlandAtroventBoehringer Ingelheim International GmbH
- IcelandAtroventBoehringer Ingelheim International GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Atrovent - Dosieraerosol, Ipratropiumbromid Infectopharm
- Belgium · Atrovent, Atrovent Hfa
- Cyprus · Atrovent
- Czechia · Atrovent, Atrovent N
- Germany · Atrovent, Atrovent Ls
- Denmark · Atrovent, Ipratropiumbromid Teva
- Estonia · Atrovent N
- Spain · Atroaldo, Atrovent
- Finland · Atrovent, Atrovent Eco
- United Kingdom (Northern Ireland) · Atrovent Inhaler Cfc-Free, Atrovent Udvs
- Greece · Atrovent, Broncovent
- Croatia · Atrovent, Atrovent N
- Hungary · Atrovent N
- Ireland · Atrovent 250 Udvs, Atrovent 500 Udvs
- Iceland · Atrovent, Lomuspray
- Italy · Atem, Nasipral
- Lithuania · Atrovent N
- Luxembourg · Atrovent, Atrovent Hfa
- Malta · Atroaldo, Atrovent Inhaler Cfc-Free
- Netherlands · Atrovent, Atrovent Unit Dose
- Norway · Atrovent, Ipraxa
- Poland · Atrodil, Atrovent
- Portugal · Atrovent, Atrovent Pa
- Romania · Ipravent Inhaler
- Sweden · Atrovent, Ipravent
- Slovakia · Atrovent N
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/05709d5b-c310-40fb-835a-21b036abddfe GET /v1/drugs/05709d5b-c310-40fb-835a-21b036abddfe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60482665",
"date_amm": "2005-03-22",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BROMURE D'IPRATROPIUM MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution pour inhalation par nébuliseur",
"voies_administration": "inhalée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about bromure d'ipratropium monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.